|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20040101920A1
(en)
|
2002-11-01 |
2004-05-27 |
Czeslaw Radziejewski |
Modification assisted profiling (MAP) methodology
|
|
US7850962B2
(en)
|
2004-04-20 |
2010-12-14 |
Genmab A/S |
Human monoclonal antibodies against CD20
|
|
US8257740B1
(en)
|
2011-08-15 |
2012-09-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US8246995B2
(en)
|
2005-05-10 |
2012-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
|
|
JP2008539785A
(ja)
*
|
2005-05-16 |
2008-11-20 |
モルフォテック、インク． |
所望の表現型を示す細胞を選択するために制御されたベクター
|
|
JP5307708B2
(ja)
|
2006-06-02 |
2013-10-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヒトｉｌ−６受容体に対する高親和性抗体
|
|
EP2450377A1
(en)
|
2006-09-07 |
2012-05-09 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
|
|
EP1947423A1
(en)
|
2007-01-16 |
2008-07-23 |
Sony Deutschland Gmbh |
Distance, orientation and velocity sensitive controller
|
|
CA2687147C
(en)
|
2007-05-11 |
2016-08-23 |
Temasek Life Sciences Laboratory Limited |
H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance
|
|
AU2008297594B2
(en)
|
2007-09-13 |
2013-06-20 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
|
|
EP2207804B1
(en)
|
2007-09-13 |
2015-07-22 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
|
|
RU2010127156A
(ru)
|
2007-12-06 |
2012-01-20 |
Дана-Фарбер Кэнсер Инститьют, Инк. (Us) |
Антитела против вируса гриппа и их применение
|
|
EP2250197B1
(en)
|
2008-02-05 |
2016-05-11 |
Temasek Life Sciences Laboratory Limited |
Binding protein and epitope-blocking elisa for the universal detection of h5-subtype influenza viruses
|
|
JP2011516423A
(ja)
|
2008-03-28 |
2011-05-26 |
シー レーン バイオテクノロジーズ， エルエルシー |
ウイルス抗原に対する中和分子
|
|
CA2731686C
(en)
|
2008-07-25 |
2020-04-07 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
EP4071169A2
(en)
|
2008-08-25 |
2022-10-12 |
Dana Farber Cancer Institute, Inc. |
Conserved influenza hemagglutinin epitope and antibodies thereto
|
|
AU2008365616A1
(en)
|
2008-12-24 |
2011-08-11 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof
|
|
EP2380976A4
(en)
|
2008-12-25 |
2012-11-07 |
Univ Osaka |
HUMAN ANTIBODY AGAINST HUMAN FLUX VIRUS
|
|
CA2761648C
(en)
|
2009-05-11 |
2019-03-12 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
CA2761681A1
(en)
|
2009-05-13 |
2010-11-18 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to influenza viruses
|
|
MY192182A
(en)
|
2009-06-26 |
2022-08-04 |
Regeneron Pharma |
Readily isolated bispecific antibodies with native immunoglobulin format
|
|
SMT202600080T1
(it)
|
2010-02-08 |
2026-03-09 |
Regeneron Pharma |
Topo con catena leggera comune
|
|
EP3098236A1
(en)
|
2010-03-08 |
2016-11-30 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
|
|
KR101849738B1
(ko)
|
2010-06-17 |
2018-04-17 |
트렐리스 바이오싸이언스 인코포레이티드 |
수동 인플루엔자 면역에 유용한 항체
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012045001A2
(en)
|
2010-09-30 |
2012-04-05 |
Vanderbilt University |
Influenza virus antibodies and immunogens and uses therefor
|
|
US8961978B2
(en)
|
2011-07-14 |
2015-02-24 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
|
|
ITRM20110606A1
(it)
|
2011-11-16 |
2013-05-17 |
Ist Superiore Sanita |
Peptidi della lattoferrina per lo uso come inibitori ad ampio spettro dellainfezione da virus della influenza.
|
|
EP2785737A2
(en)
|
2011-12-02 |
2014-10-08 |
AIMM Therapeutics B.V. |
Influenza a virus specific antibodies
|
|
MX367743B
(es)
|
2011-12-05 |
2019-09-04 |
Trellis Bioscience Llc |
Anticuerpos utiles para la inmunizacion pasiva de influenza.
|
|
SG11201405226TA
(en)
|
2012-03-08 |
2014-11-27 |
Crucell Holland Bv |
Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
|
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
|
CN104968367B
(zh)
|
2012-11-13 |
2018-04-13 |
弗·哈夫曼-拉罗切有限公司 |
抗血凝素抗体和使用方法
|
|
TWI635098B
(zh)
|
2013-02-01 |
2018-09-11 |
再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
KR20140118682A
(ko)
|
2013-03-29 |
2014-10-08 |
(주)셀트리온 |
2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물
|
|
SI3052192T1
(sl)
*
|
2013-10-02 |
2020-11-30 |
Medimmune, Llc |
Nevtralizarijoča protitelesa proti-influenci A in njihove uporabe
|
|
JP6712428B2
(ja)
*
|
2014-02-04 |
2020-06-24 |
コントラフェクト コーポレイション |
インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
|
|
TW201620932A
(zh)
|
2014-03-27 |
2016-06-16 |
建南德克公司 |
抗－ｂ型流感病毒血球凝集素抗體及其使用方法
|
|
CN104031118B
(zh)
|
2014-06-19 |
2016-04-13 |
天津大学 |
鼠多瘤病毒衣壳粒的新型亲和肽配基及其设计筛选方法
|
|
TWI702229B
(zh)
*
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
US10435462B2
(en)
|
2015-03-31 |
2019-10-08 |
Viro Dynamics Corporation |
Hybrid influenza seed viruses, compositions thereof, and use thereof in the diagnosis or therapy of influenza
|
|
KR102668588B1
(ko)
|
2015-04-08 |
2024-05-22 |
다나-파버 캔서 인스티튜트 인크. |
인간화된 인플루엔자 모노클로날 항체 및 그의 사용 방법
|
|
HUE056407T2
(hu)
|
2015-06-01 |
2022-02-28 |
Medimmune Llc |
Neutralizáló influenzaellenes kötõmolekulák és alkalmazásaik
|
|
WO2017192589A1
(en)
|
2016-05-02 |
2017-11-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to influenza ha and their use and identification
|
|
WO2020221450A1
(en)
|
2019-04-30 |
2020-11-05 |
Humabs Biomed Sa |
Antibodies and methods for treatment of influenza a infection
|